Laboratory of Dairy Research, Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens Greece.
Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, Université Lille Nord de France, CNRS UMR8204, Lille France.
Front Microbiol. 2015 Feb 17;6:58. doi: 10.3389/fmicb.2015.00058. eCollection 2015.
Over the past decades the food industry has been revolutionized toward the production of functional foods due to an increasing awareness of the consumers on the positive role of food in wellbeing and health. By definition probiotic foods must contain live microorganisms in adequate amounts so as to be beneficial for the consumer's health. There are numerous probiotic foods marketed today and many probiotic strains are commercially available. However, the question that arises is how to determine the real probiotic potential of microorganisms. This is becoming increasingly important, as even a superficial search of the relevant literature reveals that the number of proclaimed probiotics is growing fast. While the vast majority of probiotic microorganisms are food-related or commensal bacteria that are often regarded as safe, probiotics from other sources are increasingly being reported raising possible regulatory and safety issues. Potential probiotics are selected after in vitro or in vivo assays by evaluating simple traits such as resistance to the acidic conditions of the stomach or bile resistance, or by assessing their impact on complicated host functions such as immune development, metabolic function or gut-brain interaction. While final human clinical trials are considered mandatory for communicating health benefits, rather few strains with positive studies have been able to convince legal authorities with these health claims. Consequently, concern has been raised about the validity of the workflows currently used to characterize probiotics. In this review we will present an overview of the most common assays employed in screening for probiotics, highlighting the potential strengths and limitations of these approaches. Furthermore, we will focus on how the advent of omics technologies has reshaped our understanding of the biology of probiotics, allowing the exploration of novel routes for screening and studying such microorganisms.
在过去的几十年里,由于消费者对食品在促进健康和福祉方面的积极作用的认识不断提高,食品工业朝着生产功能性食品的方向发生了革命性的变化。根据定义,益生菌食品必须含有足够数量的活微生物,才能对消费者的健康有益。如今有许多益生菌食品上市,许多益生菌菌株也可商业获得。然而,问题在于如何确定微生物的真正益生菌潜力。这一点变得越来越重要,因为即使对相关文献进行简单的搜索也可以发现,宣称的益生菌数量正在迅速增加。虽然绝大多数益生菌微生物都是与食品相关或共生的细菌,通常被认为是安全的,但来自其他来源的益生菌越来越多地被报道,这引发了可能的监管和安全问题。潜在的益生菌是通过体外或体内试验选择的,通过评估简单的特征,如对胃酸或胆汁的抵抗力,或通过评估它们对复杂的宿主功能的影响,如免疫发育、代谢功能或肠道-大脑相互作用。虽然最终的人体临床试验被认为是沟通健康益处的强制性要求,但只有少数具有积极研究的菌株能够用这些健康声明来说服法定机构。因此,人们对目前用于表征益生菌的工作流程的有效性表示担忧。在这篇综述中,我们将介绍筛选益生菌最常用的检测方法概述,突出这些方法的潜在优势和局限性。此外,我们还将重点介绍组学技术的出现如何改变了我们对益生菌生物学的理解,从而为筛选和研究这些微生物开辟了新的途径。